Cancer cachexia, mechanism and treatment

Area of Science:

• Oncology
• Metabolic Medicine
• Clinical Nutrition

Background:

• Cancer cachexia affects approximately 50% of cancer patients, characterized by anorexia, inflammation, and significant loss of lean body mass.
• This syndrome severely impacts patient quality of life, response to chemotherapy, and overall survival.
• Cachexia remains underestimated and undertreated, despite its complex etiology involving cytokines and a persistent catabolic state.

Purpose of the Study:

• To review the current understanding of cancer cachexia mechanisms.
• To discuss existing and emerging treatment strategies for cancer cachexia.
• To provide an update on ongoing clinical trials for cachexia therapies.

Main Methods:

• Literature review of cancer cachexia mechanisms and treatments.
• Analysis of current therapeutic approaches, including pharmaceutical agents and multidisciplinary interventions.
• Summary of recent advancements and clinical trial data.

Main Results:

• Cancer cachexia is a complex syndrome with significant negative impacts on cancer patients.
• Current treatments focus on palliation, but novel therapies combining diet, exercise, and pharmaceuticals show promise.
• Emerging treatments have demonstrated potential for improving survival rates and quality of life.

Conclusions:

• A multidisciplinary approach integrating novel pharmaceutical agents with lifestyle modifications is crucial for managing cancer cachexia.
• Further research and clinical trials are essential to optimize treatment strategies and improve patient outcomes.
• Addressing cancer cachexia is vital for enhancing the quality of life and prognosis for cancer patients.